BDAZ - It would be nice to know if any of the patients with improvements in MOCA were also taking Biogen's new drug.

If anyone believes in miracles anymore I think the results that ABL had were better than Biogen's results without any negative brain issues. Biogen's share price went up about $160per share when their news was first released a few years ago, we went down a couple of pennies. Anyone interested in value stocks may want to reassess their understanding of RVX and the issues blocking its price progress. If it is determined that the problem(s) can be overcome then RVX may actually be the best bargain stock on the market today. Biogen's has 149 mil. shares outstanding versus our 256 mil.

tada